Literature DB >> 8145039

Granulocyte/macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophils.

M Pouliot1, P P McDonald, P Borgeat, S R McColl.   

Abstract

The synthesis of leukotrienes in human blood neutrophils chiefly relies on the activity of two enzymes, phospholipase A2 and 5-lipoxygenase (5-LO). In turn, the activation of the 5-LO requires the participation of a recently characterized membrane-bound protein, the 5-LO-activating protein (FLAP). In this study, we have investigated conditions under which FLAP expression in neutrophils may be modulated. Of several cytokines tested, only granulocyte/macrophage colony-stimulating factor (GM-CSF) (and to a lesser extent tumor necrosis factor alpha) significantly increased expression of FLAP. GM-CSF increased FLAP mRNA steady-state levels in a time- and dose-dependent manner. The stimulatory effect of GM-CSF on FLAP mRNA was inhibited by prior treatment of the cells with the transcription inhibitor, actinomycin D, and pretreatment of the cells with the protein synthesis inhibitor, cycloheximide, failed to prevent the increase in FLAP mRNA induced by GM-CSF. The accumulation of newly synthesized FLAP, as determined by immunoprecipitation after incorporation of 35S-labeled amino acids, was also increased after incubation of neutrophils with GM-CSF. In addition, the total level of FLAP protein was increased in GM-CSF-treated neutrophils, as determined by two-dimensional gel electrophoresis, followed by Western blot. GM-CSF did not alter the stability of the FLAP protein, indicating that the effect of GM-CSF on FLAP accumulation was the consequence of increased de novo synthesis as opposed to decreased degradation of FLAP. Finally, incubation of neutrophils with the synthetic glucocorticoid dexamethasone directly stimulated the upregulation of FLAP mRNA and protein, and enhanced the effect of GM-CSF. Taken together, these data demonstrate that FLAP expression may be upmodulated after appropriate stimulation of neutrophils. The increase in FLAP expression induced by GM-CSF in inflammatory conditions could confer upon neutrophils a prolonged capacity to synthesize leukotrienes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8145039      PMCID: PMC2191466          DOI: 10.1084/jem.179.4.1225

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  Gene characterization and promoter analysis of the human 5-lipoxygenase-activating protein (FLAP).

Authors:  B P Kennedy; R E Diehl; Y Boie; M Adam; R A Dixon
Journal:  J Biol Chem       Date:  1991-05-05       Impact factor: 5.157

2.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

3.  An octamer of histones in chromatin and free in solution.

Authors:  J O Thomas; R D Kornberg
Journal:  Proc Natl Acad Sci U S A       Date:  1975-07       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  Biosynthesis and biological activity of leukotriene B4.

Authors:  P Borgeat; P H Naccache
Journal:  Clin Biochem       Date:  1990-10       Impact factor: 3.281

6.  FLAP: a novel drug target for inhibiting the synthesis of leukotrienes.

Authors:  A W Ford-Hutchinson
Journal:  Trends Pharmacol Sci       Date:  1991-02       Impact factor: 14.819

7.  Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation.

Authors:  S R McColl; E Krump; P H Naccache; P E Poubelle; P Braquet; M Braquet; P Borgeat
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

8.  Granulocyte macrophage-colony stimulating factor stimulates the synthesis of membrane and nuclear proteins in murine neutrophils.

Authors:  I J Stanley; A W Burgess
Journal:  J Cell Biochem       Date:  1983       Impact factor: 4.429

9.  Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis.

Authors:  R A Dixon; R E Diehl; E Opas; E Rands; P J Vickers; J F Evans; J W Gillard; D K Miller
Journal:  Nature       Date:  1990-01-18       Impact factor: 49.962

10.  5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes.

Authors:  J W Woods; J F Evans; D Ethier; S Scott; P J Vickers; L Hearn; J A Heibein; S Charleson; I I Singer
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Regulation of expression of the 5-lipoxygenase pathway.

Authors:  T D Bigby
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

2.  Lymphocytes stimulate expression of 5-lipoxygenase and its activating protein in monocytes in vitro via granulocyte macrophage colony-stimulating factor and interleukin 3.

Authors:  W L Ring; C A Riddick; J R Baker; D A Munafo; T D Bigby
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

Review 3.  The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor.

Authors:  William S Powell; Joshua Rokach
Journal:  Prog Lipid Res       Date:  2013-09-19       Impact factor: 16.195

Review 4.  Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid.

Authors:  William S Powell; Joshua Rokach
Journal:  Biochim Biophys Acta       Date:  2014-10-29

5.  Effect of intravenous corticosteroid on ex vivo leukotriene generation by blood leucocytes of normal and asthmatic patients.

Authors:  P P Hood; T P Cotter; J F Costello; A P Sampson
Journal:  Thorax       Date:  1999-12       Impact factor: 9.139

6.  Proteinase-activated receptor-2 up-regulation by Fcgamma-receptor activation in human neutrophils.

Authors:  Mireille St-Onge; Stéphanie Lagarde; Cynthia Laflamme; Emmanuelle Rollet-Labelle; Louis Marois; Paul H Naccache; Marc Pouliot
Journal:  FASEB J       Date:  2010-02-12       Impact factor: 5.191

7.  Gene expression patterns in blood leukocytes discriminate patients with acute infections.

Authors:  Octavio Ramilo; Windy Allman; Wendy Chung; Asuncion Mejias; Monica Ardura; Casey Glaser; Knut M Wittkowski; Bernard Piqueras; Jacques Banchereau; A Karolina Palucka; Damien Chaussabel
Journal:  Blood       Date:  2006-11-14       Impact factor: 22.113

8.  In vivo dexamethasone effects on neutrophil effector functions in a rat model of acute lung injury.

Authors:  E C O'Leary; G F Evans; S H Zuckerman
Journal:  Inflammation       Date:  1997-12       Impact factor: 4.092

9.  Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils.

Authors:  M J Coffey; S M Phare; S George; M Peters-Golden; P H Kazanjian
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

Review 10.  5-Oxo-ETE and the OXE receptor.

Authors:  Gail E Grant; Joshua Rokach; William S Powell
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-05-18       Impact factor: 3.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.